Dr. Soo Boorson, President, AAGP; Dr. Barry Lebowitz, Chief, Adult and Geriatric Treatment & Preventive Interventions Research Branch, NIMH; Dr. Gary Small, Professor of Psychiatry and Biobehavioral Sciences, UCLA; Dr. Murali Doraiswamy, Associate Professor of Biological Psychiatry, Duke University Medical Center.

Sponsored by: Forest Laboratories & Parke-Davis/American Association for Geriatric Psychiatry (AAGP)

1:30 - 2:15 p.m.

"Exploring the Norepinephrine Pathway in the Treatment of Depression"

Dennis Charney, M.D., Yale University School of Medicine; Alan Schatzberg, M.D., Stanford University Hospital; Maurizio Fava, M.D., Harvard Medical School; Mary Guardino, Founder, Freedom From Fear.

Sponsored by: Pharmacia & Upjohn/Ketchum Public Relations

3:30 - 4:15 p.m.

"Schizophrenia Treatment and the New COPE Program"

Results of a multinational survey of the attitudes and perceptions of healthcare professionals, patients and their caregivers. The launch of COPE, a new program providing practical and useful information for understanding and coping with psychosis-related disorders on a day-to-day basis, also will be announced.

Sponsored by: Zeneca Pharmaceuticals/NAMI/ Burson Marsteller

3:30 - 4:15 p.m.

"Experiencing Schizophrenia"

Dan Frey , schizophrenia patient; Jacob Frey , father of schizophrenia patient; Dr. Stephen Goldfinger, Vice Chair, Psychiatry Department, SUNY Health Sciences University.

Sponsored by: Janssen Pharmaceutica/Ketchum Public Relations

3:30 - 4:15 p.m.

"Remission: Exploring New Treatment Criteria for Depression"

Dr. Michael Th
'"/>

Contact: Melissa Katz
mkatz@psych.org
202-682-6142
American Psychiatric Association
10-May-1999